BIOMERICA INC (BMRA) Stock Price, Quote, News and Summary
NASDAQ:BMRA - Nasdaq - US09061H3075 - Common Stock
BMRA Quote and Key Statistics
BIOMERICA INC
NASDAQ:BMRA (1/21/2025, 8:00:00 PM)
After market: 0.57 -0.03 (-5%)0.6
-0.04 (-6.25%)
BMRA Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -78.3% | ||
| ROE | -115.26% | ||
| Debt/Equity | 0 |
BMRA Performance and Technical Analysis
BMRA Ownership and Analysts
BMRA Latest News and Analysis
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Stay up-to-date with the latest market trends one hour before the close of the markets on Thursday. Explore the top gainers and losers during today's session in our detailed report.
Which stocks are most active on Thursday?
Discover the most active stocks in Thursday's session. Stay informed about the stocks that are generating the most trading volume!
Top movers in Thursday's session
Intrigued by the market activity in the middle of the day on Thursday? Uncover the key winners and losers of today's session in our insightful analysis.
Gapping stocks in Thursday's session
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Thursday.
Biomerica Adds Most New Retail Followers Among Biotechs After UAE Nod For Prostate Cancer Screening Test
The latest approval aligns with Biomerica’s strategy to broaden its presence in the Middle East, a region where prostate cancer is increasingly viewed as a pressing health issue.
About BMRA
Company Profile
Biomerica, Inc. engages in the development, manufacture, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company is headquartered in Irvine, California and currently employs 63 full-time employees. Its diagnostic test kits are utilized in the analysis of blood, urine, nasal, or fecal samples for the diagnosis of various diseases, food intolerances, and other medical conditions. Its range of medical diagnostic products is sold primarily in two markets: clinical laboratories and point-of-care settings, including physicians’ offices and over-the-counter sales. The company is focused on research and development efforts and is its patented diagnostic-guided therapy (DGT) product, developed on the in Foods technology platform. Its inFoods IBS product, uses a simple blood test to identify patient-specific foods that, when eliminated, may alleviate IBS symptoms such as pain, bloating, diarrhea, cramping, and constipation. Its hp+detect, a new diagnostic test for detecting Helicobacter pylori (H. pylori) bacteria in the gastrointestinal tract.
Company Info
BIOMERICA INC
17571 Von Karman Avenue
Irvine CALIFORNIA 92614 US
CEO: Zackary S. Irani
Employees: 64
Company Website: https://biomerica.com/
Investor Relations: http://investors.biomerica.com/overview/default.aspx
Phone: 19493792875
BMRA Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ISRG | INTUITIVE SURGICAL INC | 89.9 | 215.18B | ||
| ABT | ABBOTT LABORATORIES | 25.84 | 202.57B | ||
| SYK | STRYKER CORP | 34.01 | 150.91B | ||
| BSX | BOSTON SCIENTIFIC CORP | 42.76 | 148.72B | ||
| MDT | MEDTRONIC PLC | 16.83 | 113.33B | ||
| BDX | BECTON DICKINSON AND CO | 18.27 | 69.71B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.21 | 41.27B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 20.7 | 39.90B | ||
| RMD | RESMED INC | 29.89 | 36.38B | ||
| IDXX | IDEXX LABORATORIES INC | 39.03 | 34.99B | ||
| DXCM | DEXCOM INC | 50.78 | 33.72B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 19.98 | 24.97B |